靛玉红

Indirubin

未知生产厂商

Indirubin is under investigation in clinical trial NCT01735864 (Dosage Determination Trial for Indigo Naturalis Extract in Oil Ointment).

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Indirubin is under investigation in clinical trial NCT01735864 (Dosage Determination Trial for Indigo Naturalis Extract in Oil Ointment).

主要用于治疗慢性粒细胞白血病的慢性期患者，有少量报道初步认为本品对缩小伴有巨脾的骨髓纤维化患者脾脏亦可能有一定疗效。

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

显示相关度最高的 100 个专利族。

PHOTOPROTECTIVE COMPOSITIONS CONTAINING MALASSEZIA-DERIVED COMPOUNDS AND/OR CHEMICAL ANALOGS THEREOF
EP 4545147 A3申请人: VERSICOLOR TECH LLC优先权: 2018
CN
EP
US
WO
8 件公开
NANOPARTICLES OF INDIRUBIN, DERIVATIVES THEREOF AND METHODS OF MAKING AND USING SAME
EP 3597178 A1申请人: PHOSPHOREX INC优先权: 2012
CN
EP
US
6 件公开
Methods of treating an inflammatory-related disease
US 7582670 B2申请人: NATROGEN THERAPEUTICS INC优先权: 2005
US
6 件公开
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING INFLUENZA VIRUSES REPLICATION
EP 2694046 A1申请人: INST NAT SANTE RECH MED优先权: 2011
CN
EP
US
WO
5 件公开
NOVEL INDIRUBIN DERIVATIVE HAVING HETEROBICYCLIC RESIDUE AND USE THEREOF
EP 4253385 A4申请人: PELEMED CO LTD优先权: 2022
CN
EP
US
WO
4 件公开
METHOD OF TREATING AN INFLAMMATORY-RELATED DISEASE
EP 3020400 A1申请人: NATROGEN THERAPEUTICS INTERNATIONAL INC优先权: 2004
EP
US
4 件公开
Indirubin derivatives, and uses thereof
US 10435367 B2申请人: HOPE CITY优先权: 2013
US
3 件公开
Indirubin derivatives and their use for the treatment of cancer
EP 1340745 A1申请人: EISENBRAND GERHARD PROF DR优先权: 2002
EP
US
2 件公开
Conjugate of benzofuranone and indole or azaindole, and preparation and uses thereof
US 9868734 B2申请人: LUODA BIOSCIENCES INC优先权: 2013
CN
US
2 件公开
5-bromo-indirubins
US 11306072 B2申请人: HOPE CITY优先权: 2014
CN
US
2 件公开